Tara Mitchell, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 608 New Hope Rd Ste 7, Princeton, WV 24740 Phone: 304-952-2087 |
Dr. David Beihl, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 122 12th St, Princeton, WV 24740 Phone: 304-487-7000 |
Inas Hassan Al-attar, M.D. Pediatrics - Pediatric Infectious Diseases Medicare: Medicare Enrolled Practice Location: 34 New Hope Rd Ste 3, Princeton, WV 24740 Phone: 304-487-0415 Fax: 304-487-0417 |
Dr. Amira I Khokar, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 608 New Hope Rd Ste 3, Princeton, WV 24740 Phone: 304-487-6065 Fax: 304-425-5420 |
Ghazala Qureshi Khokar, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 608 New Hope Rd Ste 3, Princeton, WV 24740 Phone: 304-487-7530 Fax: 304-425-5420 |
News Archive
Siemens Healthineers has more than 30 years of central lab hemostasis leadership. Building on to its portfolio, the company announced today FDA 510(k) clearance for a hand-held portable coagulation analyzer.
Links to pesticide exposure are being found in a growing number of studies that evaluate the causes of preventable diseases - including asthma, autism and learning disabilities, birth defects and reproductive dysfunction, diabetes, Parkinson's and Alzheimer's diseases, and several types of cancer. A new database, released today, tracks published epidemiologic and real world exposure studies.
Since before the 1300s, people living in many parts of Africa have been dying from a disease known as sleeping sickness. Despite public health campaigns that explain ways to stop infection—primarily by killing the disease-spreading tsetse fly—successful eradication has remained out of reach. That's partly because epidemiologists can't predict where cases will emerge next.
Although drinking by U.S. adolescents has decreased during the last decade, more than 20 percent of U.S. high-school students continue to drink alcohol before the age of 14 years.
The Journal of the American Academy of Dermatology has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses – 2.5% and 3.75% – administered daily on either 2-week or 3-week treatment cycles.
› Verified 3 days ago